Charles Bonnet Syndrome: Three Cases

Charles Bonnet syndrome (CBS) is characterized by the presence of visual hallucinations due to the decrease in visual acuity or loss of vision without any pschiatric problem. We report three patients of aged 73, 76, and 75 years with a severe loss of vision due to ocular diseases and visual hallucin...

Full description

Bibliographic Details
Main Authors: Aygün Akbay Özşahin, Zeynep Çiğdem Diler, Sevinç Çelik, Gülay Kenangil, Füsun Domaç
Format: Article
Language:English
Published: Galenos Yayinevi 2016-12-01
Series:Türk Nöroloji Dergisi
Subjects:
Online Access:http://www.tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-25986
id doaj-7a8474673d1542fa83e8d56ae0ba53d9
record_format Article
spelling doaj-7a8474673d1542fa83e8d56ae0ba53d92021-09-02T21:52:28ZengGalenos YayineviTürk Nöroloji Dergisi1301-062X2016-12-0122418418710.4274/tnd.25986Charles Bonnet Syndrome: Three CasesAygün Akbay Özşahin0Zeynep Çiğdem Diler1Sevinç Çelik2Gülay Kenangil3Füsun Domaç4Erenköy Mental Health Research HospitalErenköy Mental Health Research HospitalErenköy Mental Health Research HospitalErenköy Mental Health Research HospitalErenköy Mental Health Research HospitalCharles Bonnet syndrome (CBS) is characterized by the presence of visual hallucinations due to the decrease in visual acuity or loss of vision without any pschiatric problem. We report three patients of aged 73, 76, and 75 years with a severe loss of vision due to ocular diseases and visual hallucinations. Case 1 was a man aged 73 years who presented with visual hallucinations that completely recovered after cataract surgery. Case 2 was woman aged 75 years with severe visual impairment from end-stage age-related macular degeneration, thus visual hallucinations continued to persist. Case 3 was legally blind with CBS-type visual hallucinations and amnestic dementia syndrome. CBS may terminate spontaneously or continue for months or years. Ideally, the patient should be considered for ophthalmologic intervention. Although CBS is benign, the visual hallucinations can cause great anxiety for patients. Patients should be warned about the adverse effects of pharmacologic therapy. Cognitive decline may occur at early stages or later.http://www.tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-25986Charles Bonnet syndromevisual hallucinationdementia
collection DOAJ
language English
format Article
sources DOAJ
author Aygün Akbay Özşahin
Zeynep Çiğdem Diler
Sevinç Çelik
Gülay Kenangil
Füsun Domaç
spellingShingle Aygün Akbay Özşahin
Zeynep Çiğdem Diler
Sevinç Çelik
Gülay Kenangil
Füsun Domaç
Charles Bonnet Syndrome: Three Cases
Türk Nöroloji Dergisi
Charles Bonnet syndrome
visual hallucination
dementia
author_facet Aygün Akbay Özşahin
Zeynep Çiğdem Diler
Sevinç Çelik
Gülay Kenangil
Füsun Domaç
author_sort Aygün Akbay Özşahin
title Charles Bonnet Syndrome: Three Cases
title_short Charles Bonnet Syndrome: Three Cases
title_full Charles Bonnet Syndrome: Three Cases
title_fullStr Charles Bonnet Syndrome: Three Cases
title_full_unstemmed Charles Bonnet Syndrome: Three Cases
title_sort charles bonnet syndrome: three cases
publisher Galenos Yayinevi
series Türk Nöroloji Dergisi
issn 1301-062X
publishDate 2016-12-01
description Charles Bonnet syndrome (CBS) is characterized by the presence of visual hallucinations due to the decrease in visual acuity or loss of vision without any pschiatric problem. We report three patients of aged 73, 76, and 75 years with a severe loss of vision due to ocular diseases and visual hallucinations. Case 1 was a man aged 73 years who presented with visual hallucinations that completely recovered after cataract surgery. Case 2 was woman aged 75 years with severe visual impairment from end-stage age-related macular degeneration, thus visual hallucinations continued to persist. Case 3 was legally blind with CBS-type visual hallucinations and amnestic dementia syndrome. CBS may terminate spontaneously or continue for months or years. Ideally, the patient should be considered for ophthalmologic intervention. Although CBS is benign, the visual hallucinations can cause great anxiety for patients. Patients should be warned about the adverse effects of pharmacologic therapy. Cognitive decline may occur at early stages or later.
topic Charles Bonnet syndrome
visual hallucination
dementia
url http://www.tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-25986
work_keys_str_mv AT aygunakbayozsahin charlesbonnetsyndromethreecases
AT zeynepcigdemdiler charlesbonnetsyndromethreecases
AT sevinccelik charlesbonnetsyndromethreecases
AT gulaykenangil charlesbonnetsyndromethreecases
AT fusundomac charlesbonnetsyndromethreecases
_version_ 1717819232395198464